{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:22:04Z","timestamp":1769523724049,"version":"3.49.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:p>The relationship between the ductal and lobular components of invasive ductolobular carcinomas (IDLC) has not been fully elucidated. In this study, the molecular alterations of both components were analyzed in a series of 20 IDLC that were selected, not only by morphologic criteria, but also by the loss of E-cadherin expression in the lobular component. We found that 80% of tumors shared alterations of driver genes in both components, being <jats:italic toggle=\"yes\">PIK3CA<\/jats:italic> the most common alteration. In addition, 45% of IDLC carried <jats:italic toggle=\"yes\">CDH1<\/jats:italic> mutations in their lobular component that were absent in the ductal component. Fluorescent in situ hybridization analysis of the <jats:italic toggle=\"yes\">CDH1<\/jats:italic> gene excluded homozygous <jats:italic toggle=\"yes\">CDH1<\/jats:italic> loss as a frequent cause of E-cadherin loss in tumors without <jats:italic toggle=\"yes\">CDH1<\/jats:italic> mutations. In addition, no pathogenic mutations of catenin genes were detected in this series of tumors. In 25% of tumors, actionable mutations in <jats:italic toggle=\"yes\">PIK3CA<\/jats:italic>, <jats:italic toggle=\"yes\">AKT1<\/jats:italic>, and <jats:italic toggle=\"yes\">ERBB2<\/jats:italic> were found in only 1 component. Altogether, our results confirm that most IDLC derive from invasive carcinoma of no special type, in which a population of cells lose E-cadherin and acquire a lobular phenotype. The frequency of <jats:italic toggle=\"yes\">CDH1<\/jats:italic> mutations in IDLC appears to be lower than in conventional invasive lobular carcinomas, suggesting the implication of alternative mechanisms of E-cadherin loss. Moreover, molecular heterogeneity between ductal and lobular areas suggests the need for molecular characterization of both components to guide targeted therapies.<\/jats:p>","DOI":"10.1097\/pas.0000000000001936","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T17:00:14Z","timestamp":1658768414000},"page":"1545-1553","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["The Clonal Relationship Between the Ductal and Lobular Components of Mixed Ductal-Lobular Carcinomas Suggested a Ductal Origin in Most Tumors"],"prefix":"10.1097","volume":"46","author":[{"given":"Bel\u00e9n","family":"P\u00e9rez-Mies","sequence":"first","affiliation":[{"name":"Department of Pathology, Hospital Ram\u00f3n y Cajal"},{"name":"Instituto Ramon y Cajal de Investigaci\u00f3n Sanitaria (IRyCIS)"},{"name":"CIBERONC"},{"name":"Faculty of Medicine, Universidad de Alcal\u00e1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Caniego-Casas","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Ram\u00f3n y Cajal"},{"name":"Instituto Ramon y Cajal de Investigaci\u00f3n Sanitaria (IRyCIS)"},{"name":"CIBERONC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Carretero-Barrio","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Ram\u00f3n y Cajal"},{"name":"Instituto Ramon y Cajal de Investigaci\u00f3n Sanitaria (IRyCIS)"},{"name":"Faculty of Medicine, Universidad de Alcal\u00e1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Biscuola","sequence":"additional","affiliation":[{"name":"CIBERONC"},{"name":"Department of Pathology, Hospital Universitario Virgen del Roc\u00edo, Sevilla, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda A.","family":"L\u00f3pez-Garc\u00eda","sequence":"additional","affiliation":[{"name":"CIBERONC"},{"name":"Department of Pathology, Hospital Universitario Virgen del Roc\u00edo, Sevilla, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hardisson","sequence":"additional","affiliation":[{"name":"CIBERONC"},{"name":"Department of Pathology, Hospital Universitario La Paz"},{"name":"Instituto de Investigaci\u00f3n Sanitaria del Hospital Universitario La Paz (IdidPAZ)"},{"name":"Faculty of Medicine, Universidad Aut\u00f3noma de Madrid"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Rosas","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Ram\u00f3n y Cajal"},{"name":"Instituto Ramon y Cajal de Investigaci\u00f3n Sanitaria (IRyCIS)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda J.","family":"L\u00f3pez Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Instituto Ramon y Cajal de Investigaci\u00f3n Sanitaria (IRyCIS)"},{"name":"Department of Gynecology, Hospital Universitario Ram\u00f3n y Cajal, Madrid"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Crist\u00f3bal","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Ram\u00f3n y Cajal"},{"name":"Instituto Ramon y Cajal de Investigaci\u00f3n Sanitaria (IRyCIS)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Pizarro","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Ram\u00f3n y Cajal"},{"name":"Instituto Ramon y Cajal de Investigaci\u00f3n Sanitaria (IRyCIS)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan M.","family":"Rosa-Rosa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Ram\u00f3n y Cajal"},{"name":"Instituto Ramon y Cajal de Investigaci\u00f3n Sanitaria (IRyCIS)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Palacios","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Ram\u00f3n y Cajal"},{"name":"Instituto Ramon y Cajal de Investigaci\u00f3n Sanitaria (IRyCIS)"},{"name":"CIBERONC"},{"name":"Faculty of Medicine, Universidad de Alcal\u00e1"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,7,25]]},"reference":[{"key":"R2-20250612","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13058-020-01384-6","article-title":"Invasive lobular carcinoma of the breast: the increasing importance of this special subtype","volume":"23","author":"McCart Reed","year":"2021","journal-title":"Breast Cancer Res"},{"key":"R3-20250612","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.3390\/cancers13153695","article-title":"Lobular breast cancer: histomorphology and different concepts of a special spectrum of tumors","volume":"13","author":"Christgen","year":"2021","journal-title":"Cancers"},{"key":"R4-20250612","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1634\/theoncologist.2018-0363","article-title":"Mixed invasive ductal and lobular carcinoma of the breast: prognosis and the importance of histologic grade","volume":"24","author":"Metzger-Filho","year":"2019","journal-title":"The Oncologist"},{"key":"R5-20250612","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","article-title":"Comprehensive molecular portraits of invasive lobular breast cancer","volume":"163","author":"Ciriello","year":"2015","journal-title":"Cell"},{"key":"R6-20250612","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/pin.12065","article-title":"Histopathological and clonal study of combined lobular and ductal carcinoma of the breast","volume":"63","author":"Tazaki","year":"2013","journal-title":"Pathol Int"},{"key":"R7-20250612","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/path.5040","article-title":"Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology: mixed ductal-lobular tumours constitute a clonal entity","volume":"244","author":"McCart Reed","year":"2018","journal-title":"J Pathol"},{"key":"R8-20250612","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1309\/AJCP7AK1VWFNMCSW","article-title":"Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases","volume":"132","author":"Wagner","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"R9-20250612","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.5858\/arpa.2018-0902-SA","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update","volume":"142","author":"Wolff","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R10-20250612","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djp082","article-title":"Ki67 index, HER2 status, and prognosis of patients with Luminal B breast cancer","volume":"101","author":"Cheang","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"R11-20250612","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/cancers11010074","article-title":"High frequency of ERBB2 activating mutations in invasive lobular breast carcinoma with pleomorphic features","volume":"11","author":"Rosa-Rosa","year":"2019","journal-title":"Cancers"},{"key":"R12-20250612","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12575-018-0084-7","article-title":"Modified SureSelectQXT target enrichment protocol for illumina multiplexed sequencing of FFPE samples","volume":"20","author":"Rosa-Rosa","year":"2018","journal-title":"Biol Proced Online"},{"key":"R14-20250612","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"key":"R15-20250612","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3390\/cancers14051151","article-title":"Differences in the molecular profile between primary breast carcinomas and their cutaneous metastases","volume":"14","author":"Gonz\u00e1lez-Mart\u00ednez","year":"2022","journal-title":"Cancers"},{"key":"R16-20250612","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/cjp2.253","article-title":"Inter\u2010observer agreement for the histological diagnosis of invasive lobular breast carcinoma","volume":"8","author":"Christgen","year":"2022","journal-title":"J Pathol CR"},{"key":"R17-20250612","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/annonc\/mdz036","article-title":"Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)","volume":"30","author":"Condorelli","year":"2019","journal-title":"Ann Oncol"},{"key":"R18-20250612","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.3390\/cancers13081950","article-title":"The genomic landscape of lobular breast cancer","volume":"13","author":"McCart Reed","year":"2021","journal-title":"Cancers"},{"key":"R19-20250612","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ijc.11197","article-title":"Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability: E-Cadherin, Catenins and APC","volume":"106","author":"Sarri\u00f3","year":"2003","journal-title":"Int J Cancer"},{"key":"R20-20250612","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2217\/epi.14.74","article-title":"The CpG island methylator phenotype in breast cancer is associated with the lobular subtype","volume":"7","author":"Roessler","year":"2015","journal-title":"Epigenomics"},{"key":"R21-20250612","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/path.5099","article-title":"\u03b1E-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer: \u03b1E-catenin is a candidate driver of invasive lobular carcinoma","volume":"245","author":"de Groot","year":"2018","journal-title":"J Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001936","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T17:00:41Z","timestamp":1749747641000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,25]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001936","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,25]]}}}